Arkolith/Insider Trading/AUPH/Form 4

Tang Kevin

DirectorAurinia Pharmaceuticals Inc. (AUPH) · full profile →Form 4 · filed Dec 9, 2024
Net Buying
Open-Market Buys
$10.8M
Open-Market Sells
$0
Net Open-Market Flow
$10.8M
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 9, 2024Buy(P)500K$9.09$4.5M8.4M
Dec 6, 2024Buy(P)400K$9.01$3.6M7.9M
Dec 5, 2024Buy(P)300K$8.91$2.7M7.5M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-028661) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML